785976

Pfizer Inc. — FEI 2416101

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 6, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)